Rchr
J-GLOBAL ID:201801017060609088   Update date: Dec. 16, 2024

Tojo Arinobu

トウジョウ アリノブ | Tojo Arinobu
Affiliation and department:
Research field  (1): Clinical pharmacy
Research theme for competitive and other funds  (40):
  • 2020 - 2023 医療人工知能におけるブラックボックスの解明
  • 2018 - 2021 Integrative analysis of genetical mutations and heterogeneity based on stemness in breast cancer cells
  • 2015 - 2018 Elucidation of breast cancer tissue diversity by integration analysis of minimum unit omics
  • 2014 - 2018 Inhibitory co-receptors as new biomarkers for bone marrow transplantation
  • 2014 - 2016 Development of diagnostic system of mutations in breast cancer by using primary spheroid cells derived from patients
Show all
Papers (494):
  • Rintaro Ono, Kenichi Sakamoto, Ko Kudo, Aki Sato, Kazuko Kudo, Hisanori Fujino, Yuta Kawahara, Hiroya Hashimoto, Takehiko Doi, Ryu Yanagisawa, et al. Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan. BMJ open. 2024. 14. 6. e084159
  • Makoto Yamagishi, Yuta Kuze, Seiichiro Kobayashi, Makoto Nakashima, Satoko Morishima, Toyotaka Kawamata, Junya Makiyama, Kako Suzuki, Masahide Seki, Kazumi Abe, et al. Mechanisms of action and resistance in histone methylation-targeted therapy. Nature. 2024
  • Akira Nishimura, Kazuaki Yokoyama, Takuya Naruto, Chika Yamagishi, Toshihiko Imamura, Hiroto Nakazono, Shunsuke Kimura, Mieko Ito, Maiko Sagisaka, Yukie Tanaka, et al. Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type. Science advances. 2023. 9. 50. eadj4407
  • Mengjiao Li, Tatsunori Nishimura, Yasuto Takeuchi, Tsunaki Hongu, Yuming Wang, Daisuke Shiokawa, Kang Wang, Haruka Hirose, Asako Sasahara, Masao Yano, et al. FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters. The Journal of clinical investigation. 2023. 133. 22
  • 横山 和明, 水澤 舞, 田上 晋, 石井 敬人, 遊佐 希, 武井 智美, 清水 英吾, 長村 登紀子, 宮野 悟, 矢野 真吾, et al. 治療抵抗性慢性骨髄単球性白血病の一例における新規RABEP1 FLT3融合遺伝子の白血病原性の検討. 日本血液学会学術集会. 2023. 85回. 554-554
more...
MISC (289):
  • Yasuto Takeuchi, Natsuko Kimura, Takahiko Murayama, Yukino Machida, Daisuke Iejima, Tatsunori Nishimura, Yuming Wang, Mizuki Yamamoto, Naoki Itano, Junichiro Inoue, et al. FRS2b fashions a cytokine-rich inflammatory microenvironment that promotes breast cancer carcinogenesis. CANCER SCIENCE. 2022. 113. 994-994
  • Li Mengjiao, Tatsunori Nishimura, Daisuke Shiokawa, Shimamura Teppei, Asako Sasahara, Masao Yano, Satoko Ishikawa, Tetsuo Ota, Keiichiro Tada, Koji Okamoto, et al. Single-cell RNAseq identifies subpopulations of drug resistant cancer stem-like cells in patient-derived breast cancer. CANCER SCIENCE. 2022. 113. 1325-1325
  • Koji Jimbo, Shuhei Koide, Takahiro Ito, Arinobu Tojo, Katsuhiro Sasaki, Kazuhiro Iwai, Atsushi Iwama, Yasuhito Nannya, Takaaki Konuma. Deficiency of the E3 Ligase Hoip Impairs Adult Hematopoiesis and Myeloid Leukemia. BLOOD. 2021. 138
  • 西村 聡, 横山 和明, 成戸 卓也, 中園 博仁, 木村 俊介, 今村 俊彦, 森尾 友宏, 金井 昭教, 松井 啓隆, 梅田 雄嗣, et al. 新規の白血病特性を有するmyeloid/natural killer cell precursor acute leukemia(Myeloid/natural killer(NK) cell precursor acute leukemia as a novel distinctive leukemia entity). 日本血液学会学術集会. 2021. 83回. PL-4
  • Miho Ogawa, Kazuaki Yokoyama, Seiya Imoto, Arinobu Tojo. Role of circulating tumor dna in hematological malignancy. Cancers. 2021. 13. 9
more...
Professional career (1):
  • 医学博士
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page